Vimarsana
Biggest News Aggregation in the World

Johnk Forrest News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johnk Forrest. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johnk Forrest Today - Breaking & Trending Today

Real-World Data Affirms Next-Gen TAVR Device Advantage - Vimarsana News

Real-World Data Affirms Next-Gen TAVR Device Advantage

TVT registry compares outcomes with Evolut FX and Pro+

A Day to Celebrate Student Research and Faculty Mentors - Vimarsana News

A Day to Celebrate Student Research and Faculty Mentors

Student research – especially the thesis – and faculty mentors were celebrated at Student Research Day on May 9, 2023.

Source: yale.edu
Initial benefit of TAVR remains consistent over the first three years among patients at low surgical risk - Vimarsana News

Initial benefit of TAVR remains consistent over the first three years among patients at low surgical risk

The number of deaths and disabling strokes among patients at low surgical risk who were treated with transcatheter aortic valve replacement (TAVR) remained lower at three years, but not significantly lower, following the TAVR procedure compared with patients who received conventional surgical aortic valve replacement (SAVR), according to new data being presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.

Self-expanding TAVR system shows durable benefits in low-risk patients at 3 years - Vimarsana News

Self-expanding TAVR system shows durable benefits in low-risk patients at 3 years

NEW ORLEANS — At 3 years, patients with severe aortic stenosis at low surgical risk who had transcatheter aortic valve replacement with a self-expanding valve continued to have lower risk for death or stroke than those who had surgical AVR. In the main results of the Evolut Low Risk Trial, risk for all-cause mortality or disabling stroke at 2 years was numerically lower and noninferior in

Source: healio.com
Benefits of TAVR Remain Consistent in Patients at Low Surgical Risk at Three Years - Vimarsana News

Benefits of TAVR Remain Consistent in Patients at Low Surgical Risk at Three Years

Rate of deaths, disabling strokes not significantly different compared to conventional surgery